51AI - The Newsletter about Applied AI

In this issue: humanoid robots, AI in real estate, Swiss pharma compliance, updated Gemini subscription plans, and Swiss luxury on Xiaohongshu.

Author

Anna Pak
May 21, 2026

51AI - The Newsletter about Applied AI

A recent real estate survey claims 82% of professionals now use AI, yet only 17% of them say it has changed their business. Why? The tools work, but the value often sits one layer deeper, in the orchestration. Enjoy reading to learn more about it!

— Mark Forster, Founder of Lab51

And just in: Google is pushing ahead with updated Gemini subscription plans, Gemini Spark AI agent, Gemini Omni, and AI search. The battle to win the consumers is in full swing! How can Microsoft counter? MORE

Humanoid Robots in Logistics: What’s Real, What’s Hype, and What to Actually Do About It in 2026

Hundreds of humanoid robots just shipped to BYD, Foxconn, and SF Express — first mass delivery ever. Same window, a survey of 27 supply chain leaders found only one actually running them. The "85% human efficiency" number is real, but only for narrow tasks under supervision. Today, the 2026 bottleneck is the orchestration layer above the robot — and less than 10% of warehouses globally are ready for that. MORE

82% of real estate pros now use AI. Only 17% say it changed their business. The gap is simple — generative AI got bought as a writing shortcut, while the real money is in agentic workflows acting across MLS, CRM, and deal pipeline at once. MORE 

Swiss watch exports to China just collapsed ~36% from the peak. While Xiaohongshu — the app Chinese buyers actually do their research on — crossed 300M users and 600M searches a day. The buyer is there, in Mandarin, asking how your watch compares to the competitors, and most Swiss heritage brands take 1–3 days to reply. A missed opportunity. By then, the purchase has often been made. MORE

Between issues, we post on LinkedIn.

Between issues, we post on LinkedIn.

Between newsletters, we're on LinkedIn Daily-ish AI updates, news, and shorter reads — follow here.

Picture a small Swiss pharma company — 180 people, one factory — held to the exact same safety and paperwork rules as Roche or Novartis. The software the big players use to handle that costs CHF 200–400k a year, just to license. The crazy part is that most of the work inside it is not expert judgment; it is sorting documents and filling forms. A handful of narrow AI agents can do that admin layer for roughly a tenth of the price. MORE

More on what's moving in AI:

Thanks for reading. Questions or thoughts — just reply to this email.